RE:RE:RE:RE:RE:MM’s Napkin Math Hard to put odds on how it might play out. Depends how many other interested parties there are, not just in Baxters dialysis business, but in the Sepsis solution piece as well - and what value they might place on the latter.
If Baxter can get full value for the latter ( not trivial) then they can avoid all the hassles of IPOing and running a second business.
At the moment I'm thinking that it's more likely PMX stays within Vantive and that Vantive is eventually spun out - perhaps a bit later than their July timeframe ( allowing time for the tire kicking)
In the meantime, Tigris ticks closer to completion with each passing week in 2024, and closer to statistical certainty as well.
MM